NCT07371117

Brief Summary

Early Childhood Caries (ECC) remains a global public health concern, necessitating minimally invasive, fluoride-based alternatives to conventional restorative therapy. Silver Diamine Fluoride (SDF), Sodium Fluoride with Casein Phosphopeptide-Amorphous Calcium Phosphate (NaF + CPP-ACP), and Acidulated Phosphate Fluoride (APF) gel are widely employed chemotherapeutic agents; however, comparative clinical evidence of their effectiveness in ECC management remains limited. This randomized controlled clinical trial will evaluate and compare the efficacy of SDF gel, NaF + CPP-ACP, and APF gel in arresting and preventing ECC.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Nov 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

January 18, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

January 18, 2026

Last Update Submit

January 18, 2026

Conditions

Keywords

silver diamine fluoride

Outcome Measures

Primary Outcomes (1)

  • Dental caries arrest

    A lesion was considered active if a blunt dental probe penetrated the dentinal surface easily, whereas arrested caries resisted probe penetration, indicating surface hardening.

    Caries arrest will be assessed 6 months after intervention

Study Arms (2)

Cavitated/Non cavitated caries lesions involving only enamel

EXPERIMENTAL

Reversible pulpitis

Drug: Silver Diamine Fluoride (SDF, 38%)Drug: Sodium Fluoride with CPP-ACPDrug: Acidulated phospahate fluoride gel 1.23%

Experimental arm including cavitated/ non cavitated caries lesions involving enamel,dentin but not p

ACTIVE COMPARATOR
Drug: Silver Diamine Fluoride (SDF, 38%)Drug: Sodium Fluoride with CPP-ACPDrug: Acidulated phospahate fluoride gel 1.23%

Interventions

This is a topical fluoride application for 1 minute application

Cavitated/Non cavitated caries lesions involving only enamelExperimental arm including cavitated/ non cavitated caries lesions involving enamel,dentin but not p

This is in a Topical fluoride varnish

Cavitated/Non cavitated caries lesions involving only enamelExperimental arm including cavitated/ non cavitated caries lesions involving enamel,dentin but not p

Silver diamine fluoride gel is applied in gel form

Cavitated/Non cavitated caries lesions involving only enamelExperimental arm including cavitated/ non cavitated caries lesions involving enamel,dentin but not p

Eligibility Criteria

Age2 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The participants who had at least one untreated cavitated active caries lesion with dentin exposed based on the Nyvad criteria (level 3: "Enamel/dentin cavity easily visible with the naked eye where the surface of cavity feels soft or leathery on gentle probing", characterized by dentin exposure without signs of pulp involvement, pain, abscess, sinus tract, or mobility.
  • Medically healthy children with no systemic disorders or developmental anomalies

You may not qualify if:

  • Parents refused consent for study
  • Any child with special health care needs or with any systemic ailments will be excluded from the study
  • Teeth exhibiting irreversible pulpitis, abscess, pathological mobility, pathological radiographic changes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentistry, jazan University

Jizan, Jazan Region, Saudi Arabia

Location

MeSH Terms

Conditions

Dental Caries

Interventions

silver diamine fluorideSodium Fluoridecasein phosphopeptide-amorphous calcium phosphate nanocomplex

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

FluoridesHydrofluoric AcidFluorine CompoundsInorganic ChemicalsSodium CompoundsCariostatic AgentsBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This three-arm phase 2 clinical trial will be conducted to evaluate the effectiveness of silver diamine fluoride (SDF) for preventing or arresting dental caries.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 18, 2026

First Posted

January 27, 2026

Study Start

November 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

We do not plan to share the IPD because we consider to continue the study for long term in future

Locations